Natus to Present at Roth Capital Partners Conference; Webcast Available on Company Web Site

Business Wire, Sept 7, 2004

SAN CARLOS, Calif. -- Natus Medial Incorporated (Nasdaq:BABY) today announced that President and Chief Executive Officer Jim Hawkins will present at the Roth Capital Partners New York conference on Monday, September 13, 2004 at 8:00 a.m. Eastern Time.

A live audio webcast of the event will be available via the "Investors" section of Natus' Web site at www.natus.com. An archived presentation will be available for 90 days. Attendance at the Roth Capital Partners New York conference is by invitation only.

About Natus

Natus develops, manufactures, and markets products for the detection, treatment, monitoring, and tracking of common disorders in newborns. Natus markets and sells its products worldwide through a direct sales force in the U.S. and the U.K. and through distributors in over 30 other countries. For more information, visit the Natus Web site at www.natus.com.

Natus' product lines include: ALGO(R) Newborn Hearing Screeners, MiniMuffs(R) Neonatal Noise Attenuators, neoBLUE(TM) LED Phototherapy device; and Neometrics(TM) software products: MSDS(TM) Metabolic Screening Database System, CMS(TM) Case Management System, WebEBP(TM) Web Based Electronic Birth Page, VRS(TM) Voice Response System. Additional information about Natus Medical can be found at www.natus.com.

Natus' trademarks include: AABR(R), Accuwell(TM), Accuscreen(TM), ALGO-1 Plus(R) Newborn Hearing Screeners, ALGO1e(R), ALGO2(R), ALGO(R), ALGO DataBook(R), CEM(TM), CMS(TM), Dri-Prep(R) Prepping Pads, Ear Couplers(R) Earphones, Flexicoupler(R) Earphones, Jelly Button(R) Sensors, Jelly Tab(R) Sensors, MiniMuffs(R) Neonatal Noise Attenuators, MSDS(TM), natus(R), neoBLUE(TM) LED Phototherapy device, Neocoat(TM), Neometrics(TM), WebEBP(TM), VRS(TM). The Biliband(R) Eye Protectors, Foldadome(TM) oxygen hoods, Igloo(R) neonatal heatshield, Oxydome(TM), Oxypod(R) and Oxy-Igloo(R) products are duly licensed to Natus by Nascor Pty. Ltd.